PRICE T ROWE ASSOCIATES INC /MD/
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in IOVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,048,296
-$1,067,386 QoQ
Shares Held
2,415,456
-23.7% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. IOVA ranks #118 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in IOVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,048,296 | 2,415,456 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,115,682 | 3,166,861 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,253,689 | 1,191,828 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,465,898 | 2,058,018 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,636,405 | 2,114,190 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,005,585 | 2,404,080 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $19,447,947 | 2,628,101 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,136,342 | 3,102,912 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $27,928,863 | 3,482,402 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $78,069,744 | 5,267,864 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $26,638,774 | 3,276,602 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $16,366,895 | 3,597,120 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,790,145 | 3,663,373 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $22,948,353 | 3,755,868 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,593,390 | 3,848,731 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $45,134,387 | 4,711,314 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,031,562 | 4,350,685 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $85,858,155 | 5,156,646 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $89,031,655 | 4,663,785 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $114,045,792 | 4,624,728 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $121,007,363 | 4,650,552 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $162,588,536 | 5,135,456 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $342,534,312 | 7,382,205 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $228,109,724 | 6,929,214 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $199,628,203 | 7,272,430 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $203,006,104 | 6,780,431 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||